Skip to main content

Peer Review reports

From: Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Original Submission
24 Oct 2022 Submitted Original manuscript
17 Apr 2023 Reviewed Reviewer Report - Tanan Bejrananda
28 Apr 2023 Reviewed Reviewer Report - Panfeng Shang
24 May 2023 Author responded Author comments - Weijuan Zhang
Resubmission - Version 2
24 May 2023 Submitted Manuscript version 2
6 Jun 2023 Author responded Author comments - Weijuan Zhang
Resubmission - Version 3
6 Jun 2023 Submitted Manuscript version 3
6 Jun 2023 Author responded Author comments - Weijuan Zhang
Resubmission - Version 4
6 Jun 2023 Submitted Manuscript version 4
14 Jun 2023 Reviewed Reviewer Report - Tanan Bejrananda
22 Jun 2023 Reviewed Reviewer Report - Panfeng Shang
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Jul 2023 Editorially accepted
14 Jul 2023 Article published 10.1186/s12885-023-11157-x

You can find further information about peer review here.

Back to article page